Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorRosell-Mases, Estela
dc.contributor.authorSantiago, Alba
dc.contributor.authorCorral Pujol, Marta
dc.contributor.authorVarela Castro, Encarna
dc.contributor.authorEgia-Mendikute, Leire
dc.contributor.authorSerrano Gómez, Gerard
dc.contributor.authorYañez, Francisca
dc.contributor.authorChaysavanh, Manichanh
dc.date.accessioned2024-01-11T13:21:17Z
dc.date.available2024-01-11T13:21:17Z
dc.date.issued2023-11-27
dc.identifier.citationRosell-Mases E, Santiago A, Corral-Pujol M, Yáñez F, Varela E, Egia-Mendikute L, et al. Mutual modulation of gut microbiota and the immune system in type 1 diabetes models. Nat Commun. 2023 Nov 27;14:7770.
dc.identifier.issn2041-1723
dc.identifier.urihttps://hdl.handle.net/11351/10836
dc.descriptionImmunological disorders; Metabolic disorders; Molecular biology
dc.description.abstractThe transgenic 116C-NOD mouse strain exhibits a prevalent Th17 phenotype, and reduced type 1 diabetes (T1D) compared to non-obese diabetic (NOD) mice. A cohousing experiment between both models revealed lower T1D incidence in NOD mice cohoused with 116C-NOD, associated with gut microbiota changes, reduced intestinal permeability, shifts in T and B cell subsets, and a transition from Th1 to Th17 responses. Distinct gut bacterial signatures were linked to T1D in each group. Using a RAG-2−/− genetic background, we found that T cell alterations promoted segmented filamentous bacteria proliferation in young NOD and 116C-NOD, as well as in immunodeficient NOD.RAG-2−/− and 116C-NOD.RAG-2−/− mice across all ages. Bifidobacterium colonization depended on lymphocytes and thrived in a non-diabetogenic environment. Additionally, 116C-NOD B cells in 116C-NOD.RAG-2−/− mice enriched the gut microbiota in Adlercreutzia and reduced intestinal permeability. Collectively, these results indicate reciprocal modulation between gut microbiota and the immune system in rodent T1D models.
dc.language.isoeng
dc.publisherNature Portfolio
dc.relation.ispartofseriesNature Communications;14
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectRatolins transgènics
dc.subjectDiabetis - Aspectes genètics
dc.subjectIntestins - Microbiologia
dc.subject.meshGastrointestinal Microbiome
dc.subject.meshDiabetes Mellitus, Type 1
dc.subject.meshMice, Transgenic
dc.titleMutual modulation of gut microbiota and the immune system in type 1 diabetes models
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1038/s41467-023-43652-x
dc.subject.decsmicrobiota intestinal
dc.subject.decsdiabetes mellitus tipo I
dc.subject.decsratones transgénicos
dc.relation.publishversionhttps://doi.org/10.1038/s41467-023-43652-x
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Rosell-Mases E, Corral-Pujol M, Egia-Mendikute L] Immunology and Immunopathology Group, Department of Experimental Medicine, Faculty of Medicine, Universitat de Lleida (UdL) and Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain. [Santiago A, Yáñez F, Varela E, Serrano-Gómez G] Grup de Recerca en Microbioma, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Manichanh C] Grup de Recerca en Microbioma, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER of Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
dc.identifier.pmid38012160
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record